Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs.
2016
Pharmacogenetic (PG) studies aim to discover the individual genetic background that underlies the heterogeneity of treatment response, and thus find biomarkers for identification of individual patients who will benefit the most from the therapy administered or urgently require the alternate drug. Ov
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
76
References
23
Citations
NaN
KQI